Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02902484
Title Study of Nintedanib and Chemotherapy for Advanced Pancreatic Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Texas Southwestern Medical Center

pancreatic adenocarcinoma


Gemcitabine + Nab-paclitaxel + Nintedanib


Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.